Product How it works Pricing Blog FAQ About Contact
Bio-Techne

Bio-Techne (NASDAQ: TECH) net income

Bio-Techne reported a net profit of $181.9m for fiscal 2026, 147.8% more than in fiscal 2025 ($73.4m). Its net margin was 15.0%. Earnings per share were $1.17.

Net income, in millions of US dollars76.12017126.2201896.12019229.32020140.42021272.12022285.32023168.1202473.42025181.92026

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2026$181.9m+147.8%15.0%$1.17
2025$73.4m−56.3%6.0%$0.47
2024$168.1m−41.1%14.5%$1.07
2023$285.3m+4.9%25.1%$1.81
2022$272.1m+93.8%24.6%$6.93
2021$140.4m−38.8%15.1%$3.62
2020$229.3m+138.7%31.0%$6.00
2019$96.1m−23.8%13.5%$2.54
2018$126.2m+65.8%19.6%$3.36
2017$76.1m—13.5%$2.04

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Questions about the net income of Bio-Techne

How much did Bio-Techne earn in fiscal 2026?
Bio-Techne reported a net profit of $181.9m for fiscal 2026. In fiscal 2025 it reported a net profit of $73.4m.
What are the earnings per share of Bio-Techne?
They were $1.17 in fiscal 2026, compared with $0.47 in fiscal 2025.
What is the net margin of Bio-Techne?
In fiscal 2026 its net profit was 15.0% of its revenue.
What was the most profitable year for Bio-Techne?
Of its last 10 fiscal years, fiscal 2023, with $285.3m.
Where do the figures for Bio-Techne come from?
From the annual report (Form 10-K) that Bio-Techne files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Bio-Techne files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Bio-Techne: the Bio-Techne page · annual accounts · revenue · dividends paid · insider transactions.

Dividend per share of Bio-Techne by fiscal year, with the filing behind every figure: Bio-Techne dividend history.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.